OCT Scanner Helps Diagnose Skin Cancers
By MedImaging International staff writers Posted on 04 Jul 2013 |
Image: The VivoSight OCT scanner (Photo courtesy of Michelson Diagnostics).
A novel skin scanning device helps dermatologists diagnose, treat, and monitor a range of commonly occurring skin cancers and other conditions.
The VivoSight OCT scanner is an advanced laser-based technology that produces high definition images of the skin up to a depth of 2 mm, using a lightweight maneuverable probe that is placed against the skin to produce the real time images. Using the generated images, dermatologists can immediately confirm the clinical diagnosis and severity of basal cell carcinoma (BCC), distinguish between a superficial actinic keratosis (AK) and a more invasive squamous cell carcinoma (SCC), and diagnose and follow treatment of nychomycosis, psoriasis and psoriatic arthritis, scleroderma, and oral cancer.
The VivoSight OCT scanner is based on Optical Coherence Tomography (OCT) technology, an optical signal acquisition and processing method that captures micrometer-resolution, three-dimensional (3D) images from within biological tissue. The probe is positioned over the tissue and can capture either 2 or 3 dimensional (2D, 3D) images of a 5 mm square region. Tissue microstructure features such as epidermis, dermis, and sub-layers can be viewed, as can subsurface blood vessels. The VivoSight OCT scanner is a product of Michelson Diagnostics (Orpington, United Kingdom).
“Dermatology today is like dentistry was before the X-ray. They look at the skin on the surface to try and guess what’s going on underneath. Often they have to take a biopsy – it’s like pulling teeth to find out if they’re rotten,” said Jon Holmes, CEO of Michelson Diagnostics, in a recent interview in The Telegraph. “There’s real potential for a scanner to pick things up earlier, enable the right treatment to be used and monitored and make sure you’ve got it all out in one go.”
“High-resolution imaging with a multibeam OCT device can accurately predict tumor margins of a BCC prior to Mohs micrographic surgery,” said dermatologist Stanley Chan MD, of Boston College (MA, USA). “The VivoSight OCT device was able to effectively depict the tumor extension. With any tumor, particularly ill-defined ones, the use of OCT could potentially reduce the number of stages required to clear the tumor leading to shorter operative times and reduction of cost.”
OCT is an interferometric technique, typically employing near-infrared (nIR) light, a relatively long wavelength light that allows it to penetrate into the scattering medium.
Related Links:
Michelson Diagnostics
The VivoSight OCT scanner is an advanced laser-based technology that produces high definition images of the skin up to a depth of 2 mm, using a lightweight maneuverable probe that is placed against the skin to produce the real time images. Using the generated images, dermatologists can immediately confirm the clinical diagnosis and severity of basal cell carcinoma (BCC), distinguish between a superficial actinic keratosis (AK) and a more invasive squamous cell carcinoma (SCC), and diagnose and follow treatment of nychomycosis, psoriasis and psoriatic arthritis, scleroderma, and oral cancer.
The VivoSight OCT scanner is based on Optical Coherence Tomography (OCT) technology, an optical signal acquisition and processing method that captures micrometer-resolution, three-dimensional (3D) images from within biological tissue. The probe is positioned over the tissue and can capture either 2 or 3 dimensional (2D, 3D) images of a 5 mm square region. Tissue microstructure features such as epidermis, dermis, and sub-layers can be viewed, as can subsurface blood vessels. The VivoSight OCT scanner is a product of Michelson Diagnostics (Orpington, United Kingdom).
“Dermatology today is like dentistry was before the X-ray. They look at the skin on the surface to try and guess what’s going on underneath. Often they have to take a biopsy – it’s like pulling teeth to find out if they’re rotten,” said Jon Holmes, CEO of Michelson Diagnostics, in a recent interview in The Telegraph. “There’s real potential for a scanner to pick things up earlier, enable the right treatment to be used and monitored and make sure you’ve got it all out in one go.”
“High-resolution imaging with a multibeam OCT device can accurately predict tumor margins of a BCC prior to Mohs micrographic surgery,” said dermatologist Stanley Chan MD, of Boston College (MA, USA). “The VivoSight OCT device was able to effectively depict the tumor extension. With any tumor, particularly ill-defined ones, the use of OCT could potentially reduce the number of stages required to clear the tumor leading to shorter operative times and reduction of cost.”
OCT is an interferometric technique, typically employing near-infrared (nIR) light, a relatively long wavelength light that allows it to penetrate into the scattering medium.
Related Links:
Michelson Diagnostics
Latest General/Advanced Imaging News
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging
- State-Of-The-Art System Enhances Accuracy of Image-Guided Diagnostic and Interventional Procedures
- Catheter-Based Device with New Cardiovascular Imaging Approach Offers Unprecedented View of Dangerous Plaques
- AI Model Draws Maps to Accurately Identify Tumors and Diseases in Medical Images